Preprocedural high-sensitive troponin predicts survival after transcatheter aortic valve implantation (TAVI)

Derk Frank; Sophia Stark; Matthias Lutz; Anne Weissbrodt; Sandra Freitag-Wolf; Rainer Petzina; Mark Rosenberg; Georg Lutter; Norbert Frey

doi:10.1016/j.ijcard.2013.08.108

Preprocedural high-sensitive troponin predicts survival after transcatheter aortic valve implantation (TAVI)

Int J Cardiol. 2013 Nov 5;169(3):e38-9. doi: 10.1016/j.ijcard.2013.08.108. Epub 2013 Sep 8.

Authors

Derk Frank¹, Sophia Stark, Matthias Lutz, Anne Weissbrodt, Sandra Freitag-Wolf, Rainer Petzina, Mark Rosenberg, Georg Lutter, Norbert Frey

Affiliation

¹ Department of Cardiology and Angiology, UKSH, University of Kiel, Germany. Electronic address: [email protected].

PMID: 24063930
DOI: 10.1016/j.ijcard.2013.08.108

No abstract available

Keywords: AR; Aortic stenosis; Biomarkers; C-reactive protein; CRP; LBBB; N-terminal b-type natriuretic peptide; NTproBNP; Prognosis; TA; TAVI; TAVI/TAVR; TF; Transcatheter aortic valve implantation/replacement; aortic regurgitation; high sensitive troponin T; hsTnT; left bundle branch block; transapical access; transfemoral access.

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Aortic Valve Stenosis / blood*
Aortic Valve Stenosis / mortality*
Aortic Valve Stenosis / surgery
Biomarkers / blood
Cardiac Catheterization / adverse effects
Cardiac Catheterization / mortality*
Female
Follow-Up Studies
Heart Valve Prosthesis Implantation / adverse effects
Heart Valve Prosthesis Implantation / mortality*
Humans
Male
Predictive Value of Tests
Preoperative Care / methods
Preoperative Care / mortality*
Prospective Studies
Sensitivity and Specificity
Survival Rate / trends
Troponin / blood*

Substances

Biomarkers
Troponin